Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Alembic Pharmaceuticals Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (320)
ARTG (171)
Prescription medicine registration (8)

Date

2024 (12)
2023 (257)
2022 (10)
2021 (84)
2020 (22)
2019 (2)
2018 (27)
2017 (48)
2016 (3)
2015 (11)
2013 (17)
2012 (6)

Results for "[search-keyword]"

Search

Sponsor content

499 result(s) found, displaying 241 to 250

OLMESARTAN HCT AGH 20/25 olmesartan medoxomil/hydrochlorothiazide 20/25 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
OLMESARTAN AGH olmesartan medoxomil 10 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
CANDESARTAN AGH candesartan cilexetil 4 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
CANDESARTAN AGH candesartan cilexetil 16 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
CANDESARTAN AGH candesartan cilexetil 32 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
CANDESARTAN AGH candesartan cilexetil 32 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
CANDELEM candesartan cilexetil 4 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
CANDESARTAN AGH candesartan cilexetil 8 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
CANDELEM candesartan cilexetil 8 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
CANDELEM candesartan cilexetil 16 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd

Pages

First page
Previous page
…
Page 21
Page 22
Page 23
Page 24
Current page 25
Page 26
Page 27
Page 28
Page 29
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.